• Royalty Pharma average return on investment for 2023 was 2.98, a 26.27% increase from 2022.
• Royalty Pharma average return on investment for 2022 was 2.36, a 54.96% increase from 2021.
• Royalty Pharma average return on investment for 2021 was 5.24, a 52.06% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.